Inc., a clinical-stage biotechnology company developing novel small molecule therapies to modulate critical RNA ...
TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI ® (ublituximab-xiiy), to be presented at the Americas Committee for Treatment and ...
BGE-102 has the potential for therapeutic retinal exposure with oral delivery, reducing treatment burden in ocular indications currently treated ...
National Clinical Trials Network (NCTN) group focused on improving outcomes for adults with cancer through multi-center clinical research, recently announced changes in leadership across multiple ...
The Food and Drug Administration (FDA) has issued a new guidance document entitled “Enhancing Participation in Clinical Trials – Eligibility Criteria, Enrollment Practices, and Trial Decision.” The ...
Oncology clinical trials drive some of the most important advances in medicine, yet they remain some of the most challenging to design and run. Intensive assessments, frequent amendments, complex ...
Improvements in medical therapy, carotid-artery stenting, and carotid endarterectomy call into question the preferred management of asymptomatic carotid stenosis. Whether adding revascularization to ...
The antibody drug market value is expected to reach $445 billion in the next five years, with over 160 antibodies currently licensed globally for a wide breadth of conditions, including cancer, ...
TCT 704: Outcomes After LAAC Using a Fluoropolymer Coated Device in Patients of Historically Underrepresented Racial and Ethnic Groups: A Sub-analysis of the HEAL-LAA Post Approval Study Receive the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results